Mark L Perry bought stock once, on Aug 17, 2015

Mark L. Perry is a corporate director and independent consultant with extensive experience in the biotechnology and technology sectors, best known for his long tenure as a director of NVIDIA Corporation (NVDA).( He joined NVIDIA’s board in 2005 and has served in key governance roles, including lead independent director, while more recently trading shares as a corporate insider in his capacity as a director.( In addition to NVIDIA, Perry has served on multiple public and private company boards, including MyoKardia, Inc. and Global Blood Therapeutics, Inc., and consults for various companies and non-profit organizations.(

Earlier in his career, Perry held senior executive roles in the biopharmaceutical industry, serving as president and CEO of Aerovance, Inc. from 2007 to 2011 and as an executive officer at Gilead Sciences, Inc. from 1994 to 2004, where his responsibilities included positions as general counsel, chief financial officer, and executive vice president of operations, overseeing worldwide sales and marketing, legal, manufacturing, and facilities.( Before entering industry, he practiced law at Cooley LLP from 1981 to 1994, becoming a partner at the firm.( Perry holds a B.A. in History from the University of California, Berkeley and a J.D. from the University of California, Davis School of Law, and has also served as an Entrepreneur-in-Residence at Third Rock Ventures, advising life sciences portfolio companies on business and financial strategy.(

Written by Perplexity from public sources.